Arrowhead Pharmaceuticals Inc (ARWR) stock news · rev $829.4M
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
This ARWR news page leads with what Arrowhead Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for ARWR yet. We will not pad this page with generic market recap.
Latest reported ARWR revenue for 2025-09-30 was $829.4M. Net income was -$1.6M. Revenue was up 23258.2% from 2024-09-30 to 2025-09-30. ARWR currently screens at market cap $10.59B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ARWR stock page; for the tape open the quote page.
ARWR stock news FAQ
What are ARWR's latest revenue and net income?
Latest cached Arrowhead Pharmaceuticals Inc (ARWR) revenue for Sep 30, 2025 was $829.4M. Net income was -$1.6M. Statements: https://lician.com/financials/arwr
How did ARWR revenue change from the prior cached period?
Cached Arrowhead Pharmaceuticals Inc (ARWR) revenue was up 23258.2% from $3.6M (Sep 30, 2024) to $829.4M (Sep 30, 2025). Statements: https://lician.com/financials/arwr
What is ARWR's market cap?
Arrowhead Pharmaceuticals Inc (ARWR) market cap is $10.59B on the latest cached fundamentals snapshot.
What kind of company is ARWR?
Arrowhead Pharmaceuticals Inc (ARWR) is a biotechnology company listed on US.
Where is ARWR stock news listed?
Cached stock news for Arrowhead Pharmaceuticals Inc (ARWR) is listed at https://lician.com/news/arwr. Filings: https://lician.com/sec/arwr
Not investment advice.